ICON Launches Innovative Safety Application to Trend and Graph Laboratory Values
10 Juin 2010 - 10:00AM
Business Wire
ICON plc (NASDAQ:ICLR), a global provider of outsourced
development services to the pharmaceutical, biotechnology and
medical device industries, today announced the launch of the
ICOLabs™ Medical Review Application (IMRA) an innovative web based
laboratory application that enables more efficient use of medical
monitoring time.
The application is ICON’s latest innovation in the drive to
expedite the medical management of study subjects. IMRA trends and
graphs real-time laboratory values enabling physicians and medical
monitors to respond faster to important safety signals earlier in
the development process.
Tom O’Leary, President, ICON Central Laboratories, commented:
“IMRA satisfies an important need in clinical trials by reducing
data review times, which in turn, improves the management of study
subjects and enables physicians to expedite the medical management
of clinically significant findings.” He continued: “By automating a
currently labour intensive process, we can drive down development
costs for sponsors while offering 24/7, global access to the latest
laboratory data, including detailed analysis of potential trends,
signals, alerts and patient-specific data.”
IMRA was developed by ICON physicians specifically for use by
fellow physicians, so the application is easy to use and displays
data in intuitive ways. On average, the client data within the
application is no more than a few hours old, allowing for real-time
evaluation of trends, signals and alerts. Additional features of
the application include up-to-date alert overviews, intuitive data
trending, detailed subject profiling and comprehensive data export
tools.
Notes to
Editors:
About ICON plc:
ICON plc is a global provider of outsourced development services
to the pharmaceutical, biotechnology and medical device industries.
The Company specialises in the strategic development, management
and analysis of programs that support clinical development - from
compound selection to Phase I-IV clinical studies. ICON currently
employs over 7,300 employees, operating from 71 locations in 39
countries.
For further information, please visit www.iconplc.com
About ICON Central Laboratories
ICON Central Laboratories, a division of ICON plc, provides full
service, global central laboratory services from facilities in New
York, Dublin and Singapore, and India . An extensive test menu of
safety, esoteric and custom-developed assays, including global flow
cytometry, is complemented by dedicated, sponsor-specific project
teams and a single, comprehensive database for each study as well
as a user-friendly, web-based, secure remote data access system.
ICON Central Laboratories also offers a unique service to manage
and compile laboratory data when a client’s study requires the use
of local laboratories.
ICON/ICLR-G
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024